Clinical Study

Quality of Life and Volume Reduction in Women with Secondary Lymphoedema Related to Breast Cancer

Table 2

Response therapeutic for lymphedema treatment.

Volume of the ULBefore treatmentAfter treatmentDifference (before, after)Wilcoxon signed-rank test
Mean95% CI Negative
Positive
Unchanged
MeanMeanLower Higher

Excess volume between the upper limbs 776.16494.51281.65 mL218.57344.735610<0.001
Percentage of excess volume between the upper limbs44.20%29.18%15.02%11.5218.535340<0.001

The mean difference between the beginning and end of treatment was analyzed using Wilcoxon test; Kolmogrov-Smirnov test > 0,05.
Volume tracking < initial volume. Volume tracking > initial volume. Volume tracking = initial volume.
CI: confidence interval; : number of patients.